You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Copy file name to clipboardExpand all lines: Clinical-Trials/RCT/RCT.Rmd
+51-1
Original file line number
Diff line number
Diff line change
@@ -15,7 +15,7 @@ This is an R Markdown document. Markdown is a simple formatting syntax for autho
15
15
16
16
When you click the **Knit** button a document will be generated that includes both content as well as the output of any embedded R code chunks within the document. You can embed an R code chunk like this:
17
17
18
-
The data is from Jama Cardiology on Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks Meta-analysis of 10 Trials Involving 77917 Individuals
18
+
The data is from Jama Cardiology on Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks Meta-analysis of 10 Trials Involving 77917 Individuals.
This is an R Markdown document. Markdown is a simple formatting syntax for authoring HTML, PDF, and MS Word documents. For more details on using R Markdown see <http://rmarkdown.rstudio.com>.
15
+
16
+
When you click the **Knit** button a document will be generated that includes both content as well as the output of any embedded R code chunks within the document. You can embed an R code chunk like this:
Copy file name to clipboardExpand all lines: README.md
+3-1
Original file line number
Diff line number
Diff line change
@@ -159,7 +159,9 @@ The issue regarding combining data from RCT and observational studies in the set
159
159
160
160
161
161
### RCT
162
-
Revman is an excellent tool for performing meta-analysis of trials but lacks the flexibility of R packages. Here we will use metafor package, see rct.Rmd. The following methods are demonstrated: fixed effect and random effect analyses, forest plot, funnel plot (for exploring publication bias), Baujat plot (for exploring source of heterogeneity) and GOSH plot (for exploring study heterogeneity using output of fixed effect model for all possible subsets). The data is from Jama Cardiology 2020 on Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks Meta-analysis of 10 Trials Involving 77917 Individuals.
162
+
Revman is an excellent tool for performing meta-analysis of trials but lacks the flexibility of R packages. Here we will use metafor package, see RCT.Rmd. The following methods are demonstrated: fixed effect and random effect analyses, forest plot, funnel plot (for exploring publication bias), Baujat plot (for exploring source of heterogeneity) and GOSH plot (for exploring study heterogeneity using output of fixed effect model for all possible subsets).
163
+
The data is from Jama Cardiology 2020 on Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks Meta-analysis of 10 Trials Involving 77917 Individuals. Subsequently a meta-analysis in J Am Heart
164
+
Assoc. 2019;8:e013543. DOI: 10.1161/JAHA.119.013543 reported that contrary to the earlier meta-analysis, Omega-3 lowers the risk of cardiovascular diseases with effect related to dose. The analysis using DerSimonian Laird method is provided in RCT.Rmd and Hartung Knapp method is provided in RCT_omega13.Rmd.
163
165
164
166
Funnel plot of RCT on Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
0 commit comments